Pharmabiz

Longevity healthcare startup Vytalyou raises Rs. 9 crore to expand clinic network

Longevity healthcare startup Vytalyou raises Rs. 9 crore to expand clinic network: Our Bureau, Mumbai Thursday, October 1, 2026, 13:30 Hrs [IST] Vytalyou, a doctor-led longevity a ...
Pharmabiz

Shilpa Biologicals launches SB HiMax platform at CPHI Milan

Shilpa Biologicals, a subsidiary of Shilpa Medicare , launches its new gene to GMP manufacturing platform, SB HiMax which ...
Pharmabiz

DBV Technologies submits BLA to US FDA for Viaskin peanut patch in children aged 4 to 7 tears

DBV Technologies submits BLA to US FDA for Viaskin peanut patch in children aged 4 to 7 tears: Châtillon, France Thursday, October 1, 2026, 18:00 Hrs [IST] DBV Technologies, a la ...
Pharmabiz

Biotech firm PreferCo names Shakthi M. Nagappan as CMD

PreferCo, a precision fermentation company headquartered in Hyderabad, announced that Shakthi Nagappan will lead the company ...
Pharmabiz

Takeda announces positive data from three phase 3 LATITUDE psoriasis studies of zasocitinib in adults with moderate-to-severe plaque psoriasis

Takeda announces positive data from three phase 3 LATITUDE psoriasis studies of zasocitinib in adults with moderate-to-severe plaque psoriasis: Osaka, Japan Thursday, October 1, 2 ...
Pharmabiz

Merck’s tulisokibart meets primary and key secondary endpoints in phase 2b study in patients with moderate to severe hidradenitis suppurativa

Merck’s tulisokibart meets primary and key secondary endpoints in phase 2b study in patients with moderate to severe hidradenitis suppurativa: Rahway, New Jersey Thursday, Octob ...
Pharmabiz

Cytrellis Biosystems partners with KoreAx Company for commercialization of ellacor micro-coring technology in South Korea

Cytrellis Biosystems partners with KoreAx Company for commercialization of ellacor micro-coring technology in South Korea: Woburn, Massachusetts Thursday, October 1, 2026, 12:00 H ...
Pharmabiz

US FDA accepts Roche’s NDA for fenebrutinib in both relapsing and primary progressive multiple sclerosis

US FDA accepts Roche’s NDA for fenebrutinib in both relapsing and primary progressive multiple sclerosis: Basel Thursday, October 1, 2026, 09:00 Hrs [IST] Roche announced that t ...
Pharmabiz

Piramal Pharma Solutions and NP2 to complete cyclophosphamide development phase in October

Piramal Pharma Solutions and NP2 to complete cyclophosphamide development phase in October: Our Bureau, Mumbai Thursday, October 1, 2026, 14:30 Hrs [IST] Piramal Pharma Solutions, ...
Pharmabiz

Truevis Technologies and Neusoft to strengthen Pan-India medical imaging support

Truevis Technologies and Neusoft to strengthen Pan-India medical imaging support: Our Bureau, Mumbai Thursday, October 1, 2026, 15:45 Hrs [IST] Truevis Technologies Pvt. Ltd., in ...
Pharmabiz

Acrotech Biopharma launches Adquey in US

Acrotech Biopharma Inc., a biopharmaceutical company focused on developing and commercializing innovative proprietary medicines, announced the US launch of Adquey (difamilast 1%) ointment, a ...
Pharmabiz

TriLink BioTechnologies receives additional patent from China for CleanCap technology

TriLink BioTechnologies receives additional patent from China for CleanCap technology: San Diego Thursday, October 1, 2026, 17:00 Hrs [IST] TriLink BioTechnologies LLC, part of Li ...